POLG2
DNA polymerase subunit gamma-2
Also known as: DPOG2_HUMAN, HP55, MTPOLB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHN1
- Gene
- POLG2
- Ensembl
- ENSG00000256525
- Chromosome
- 17
- Canonical length
- 485 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the processivity subunit of the mitochondrial DNA polymerase gamma. The encoded protein forms a heterotrimer containing one catalytic subunit and two processivity subunits. This protein enhances DNA binding and promotes processive DNA synthesis. Mutations in this gene result in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
485 residues, UniProt reviewed canonical sequence.
>Q9UHN1|POLG2
1 MRSRVAVRAC HKVCRCLLSG FGGRVDAGQP ELLTERSSPK GGHVKSHAEL EGNGEHPEAP
61 GSGEGSEALL EICQRRHFLS GSKQQLSRDS LLSGCHPGFG PLGVELRKNL AAEWWTSVVV
121 FREQVFPVDA LHHKPGPLLP GDSAFRLVSA ETLREILQDK ELSKEQLVAF LENVLKTSGK
181 LRENLLHGAL EHYVNCLDLV NKRLPYGLAQ IGVCFHPVFD TKQIRNGVKS IGEKTEASLV
241 WFTPPRTSNQ WLDFWLRHRL QWWRKFAMSP SNFSSSDCQD EEGRKGNKLY YNFPWGKELI
301 ETLWNLGDHE LLHMYPGNVS KLHGRDGRKN VVPCVLSVNG DLDRGMLAYL YDSFQLTENS
361 FTRKKNLHRK VLKLHPCLAP IKVALDVGRG PTLELRQVCQ GLFNELLENG ISVWPGYLET
421 MQSSLEQLYS KYDEMSILFT VLVTETTLEN GLIHLRSRDT TMKEMMHISK LKDFLIKYIS
481 SAKNVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- ovary: 6.2 nTPM
- skeletal muscle: 6.1 nTPM
- thymus: 5.9 nTPM
- spleen: 5.4 nTPM
- lymph node: 5 nTPM
Single-cell type
- salivary myoepithelial cells: 155 nCPM
- endometrial luminal cells: 143 nCPM
- breast lactating cells: 135 nCPM
- breast myoepithelial cells: 125 nCPM
- endometrial stromal cells: 125 nCPM
- paneth cells: 124 nCPM
Immune cell
- naive B-cell: 12 nTPM
- memory B-cell: 11 nTPM
- naive CD4 T-cell: 9.8 nTPM
- myeloid DC: 9.7 nTPM
- naive CD8 T-cell: 9.7 nTPM
- non-classical monocyte: 8.4 nTPM
Brain region
- cerebellum: 5.4 nTPM
- white matter: 4.9 nTPM
- hypothalamus: 4.7 nTPM
- medulla oblongata: 3.9 nTPM
- pons: 3.7 nTPM
- thalamus: 3.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POLG2.
Disease | AllUniProt
Conditions POLG2 is implicated in, by any mechanism.
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) MIM:610131
- Mitochondrial DNA depletion syndrome 16, hepatic type (MTDPS16) MIM:618528
- Mitochondrial DNA depletion syndrome 16B, neuroophthalmic type (MTDPS16B) MIM:619425
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 573 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4
- POLG2-related disorder
- Mitochondrial DNA depletion syndrome 16 (hepatic type)
- Mitochondrial dna depletion syndrome 16B (neuroophthalmic type)
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.35
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA-templated DNA replication
- in utero embryonic development
- mitochondrial DNA replication
- mitochondrion organization
- positive regulation of DNA-directed DNA polymerase activity
Molecular functions
- DNA polymerase binding
- DNA polymerase processivity factor activity
- DNA-directed DNA polymerase activity
- double-stranded DNA binding
- identical protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POLG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLG2 as an antibody target. Whether an autoantibody or antibody against POLG2 could matter depends on whether native POLG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLG2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...